These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15755558)

  • 1. A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes.
    Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Yarasheski KE; Smith SR; Williamson JR; Peterson RG; Oates PJ
    Exp Neurol; 2005 Apr; 192(2):407-19. PubMed ID: 15755558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sorbitol dehydrogenase exacerbates autonomic neuropathy in rats with streptozotocin-induced diabetes.
    Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Parvin CA; Yarasheski KE; Smith SR; Lang HJ; Williamson JR; Ido Y
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1153-69. PubMed ID: 11764088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy.
    Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Williamson JR; Ido Y
    J Neuropathol Exp Neurol; 1998 Dec; 57(12):1175-89. PubMed ID: 9862641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy.
    Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Zhang W; Sima AA
    J Neuropathol Exp Neurol; 2004 May; 63(5):450-60. PubMed ID: 15198124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy.
    Schmidt RE; Dorsey DA; Beaudet LN; Peterson RG
    Am J Pathol; 2003 Jul; 163(1):21-8. PubMed ID: 12819007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of NGF and neurotrophin-3 treatment on experimental diabetic autonomic neuropathy.
    Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Escandon E
    J Neuropathol Exp Neurol; 2001 Mar; 60(3):263-73. PubMed ID: 11245210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sorbinil, dietary myo-inositol supplementation, and insulin on resolution of neuroaxonal dystrophy in mesenteric nerves of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Coleman BD; Williamson JR; Tilton RG
    Diabetes; 1991 May; 40(5):574-82. PubMed ID: 1902427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats.
    Tilton RG; Chang K; Nyengaard JR; Van den Enden M; Ido Y; Williamson JR
    Diabetes; 1995 Feb; 44(2):234-42. PubMed ID: 7859946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aminoguanidine on the frequency of neuroaxonal dystrophy in the superior mesenteric sympathetic autonomic ganglia of rats with streptozocin-induced diabetes.
    Schmidt RE; Dorsey DA; Beaudet LN; Reiser KM; Williamson JR; Tilton RG
    Diabetes; 1996 Mar; 45(3):284-90. PubMed ID: 8593931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between osmotic and oxidative stress in diabetic precataractous lens: studies with a sorbitol dehydrogenase inhibitor.
    Obrosova IG; Fathallah L; Lang HJ
    Biochem Pharmacol; 1999 Dec; 58(12):1945-54. PubMed ID: 10591149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural and biochemical characterization of autonomic neuropathy in rats with chronic streptozotocin diabetes.
    Schmidt RE; Plurad SB
    J Neuropathol Exp Neurol; 1986 Sep; 45(5):525-44. PubMed ID: 3746343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticataract activity of analogs of a sorbitol dehydrogenase inhibitor.
    Kador PF; Inoue J; Blessing K
    J Ocul Pharmacol Ther; 2004 Aug; 20(4):333-44. PubMed ID: 15321028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pancreatic islet transplantation and insulin therapy on neuroaxonal dystrophy in sympathetic autonomic ganglia of chronic streptozocin-diabetic rats.
    Schmidt RE; Plurad SB; Olack BJ; Scharp DW
    Brain Res; 1989 Sep; 497(2):393-8. PubMed ID: 2510903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in cardiac muscle fructose content in streptozotocin-induced diabetic rats.
    Kashiwagi A; Obata T; Suzaki M; Takagi Y; Kida Y; Ogawa T; Tanaka Y; Asahina T; Ikebuchi M; Saeki Y
    Metabolism; 1992 Oct; 41(10):1041-6. PubMed ID: 1406291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
    Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy.
    Obrosova IG; Stevens MJ; Lang HJ
    Pharmacology; 2001; 62(3):172-80. PubMed ID: 11287819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic autoimmune nerve growth factor deprivation on sympathetic neuroaxonal dystrophy in rats.
    Schroer JA; Beaudet LN; Schmidt RE
    Synapse; 1995 Jul; 20(3):249-56. PubMed ID: 7570357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.